Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting

PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (OTCID: IDXG) (“Interpace” or the “Company”), an emerging leader in enabling personalized medicine, today announced that it will effect a 1-for-5 reverse stock split (“Reverse Stock Split”) of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on August 27, 2026, and Interpace common stock is expected to begin trading on a split-adjusted basis on the OTCID quotation system (“OTCID”) as of the commencement of market open that same day. Interpace’s ticker symbol on the OTCID will temporarily change to IDXGD for a period of 20 trading days, including the effective date. The new CUSIP number for the common stock following the Reverse Stock Split will be 46062X402.

INDEPENDENT BOARD UPDATE ON OFFER

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Connections Live 2026 Showcases How Modernized Platforms, Connected Workflows, and AI Are Reshaping Convenience Retail

Annual PDI Technologies conference highlighted innovations designed to help retailers, wholesalers, and brands improve productivity, accelerate decision making, and drive growth

Annual PDI Technologies conference highlighted innovations designed to help retailers, wholesalers, and brands improve productivity, accelerate decision making, and drive growth

Karman Line Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on August 27, 2026

BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) — Karman Line Acquisition Corp. (Nasdaq: XTERU) (the “Company”), a special purpose acquisition company, today announced that, commencing on August 27, 2026, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units.